DW Boulton

Publications

Citations

H-Index

2002

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

DW Boulton is an author at Bristol-Myers Squibb (United States) specializing in pre-clinical pharmacology, pharmacokinetic modeling, and clinical pharmacology.

Top concepts

MedicineBiochemistryPharmacologyDrug AnalysisPharmacotherapyPharmacokineticsSystems PharmacologyClinical PharmacologyMolecular PharmacologyPharmacodynamic Modeling

Publications per year

2002–2014

Publications

Evaluation of 4β‐Hydroxycholesterol as a Clinical Biomarker of CYP3A4 Drug Interactions Using a Bayesian Mechanism–Based Pharmacometric Model

Sreeneeranj Kasichayanula, DW Boulton, Frank LaCreta · CPT Pharmacometrics & Systems Pharmacology · 2014 · 37 citations · Full text

Pharmacotherapy, System Pharmacology, Experimental Pharmacology +20

The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder

DW Boulton, K. Royzman, C G Patel et al. · Journal of Psychopharmacology · 2008 · 27 citations

A Pharmacokinetic Interaction Study Between Butorphanol and Sumatriptan Nasal Sprays in Healthy Subjects: Importance of the Timing of Butorphanol Administration

N. Vachharajani, W. C. Shyu, PS Nichola et al. · Cephalalgia · 2002 · 18 citations

Rows per page

1–3 of 3